2140P Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: A cost-effectiveness analysis of the SANO-trial
Bianca Mostert(Erasmus MC), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Camiel Rosman(Radboud University Nijmegen), Hester F. Lingsma(Erasmus MC), S. Gangaram-Panday(Erasmus MC), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Johanna van Sandick(The Netherlands Cancer Institute), Joos Heisterkamp, Edwin van der Zaag(Gelre Hospitals), SM Lagarde(Erasmus MC), Ben M. Eyck(Erasmus MC Cancer Institute), Meindert N. Sosef(Zuyderland Medisch Centrum), JJB van Lanschot(Erasmus MC), E.A. Kouwenhoven(Ziekenhuis Groep Twente), J Dekker(Reinier de Graaf Hospital), H.H. Hartgrink(Leiden University Medical Center), J. P. E. N. Pierie(Medisch Centrum Leeuwarden), David van Klaveren(Erasmus MC), P-P. Coene(Maasstad Ziekenhuis), Berend J. van der Wilk(Erasmus MC Cancer Institute)
Cited by 1
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
Symptomatology and Functional Outcome in Mild Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study
|Journal of Neurotrauma|2013|517